Company news_innoModel-Provide preclinical pharmacological services

Cn /En

News Center

——

Company news

Industry news

09-25

In Vitro Killing Experimental Platform from InnoModels Biotechnology

In the vast field of life science and drug discovery, in vitro experimental platforms play a crucial role. As a leader in this field, InnoModels Biotechnology (Beijing) Co., Ltd. provides scientists with a highly controlled and precise experimental environment with its in vitro killing platform, which greatly facilitates the screening of new drugs, the study of drug mechanisms, and the development of immunotherapies.

09-20

Application Prospects of InnoModels High Mesenchymal Tumor Model

In the broad field of tumor research and new drug development for tumor immunotherapy, InnoModels Biotechnology (Beijing) Co., Ltd. has successfully launched a high mesenchymal tumor transplantation model by virtue of its profound accumulation and technological innovation in the field of model construction, which provides strong support for tumor research and drug development. In this article, we will introduce in detail how InnoModels Biotechnology has made a breakthrough in this field, and explain the importance of high mesenchymal tumor models and their application prospects.

09-19

Advantages of the 3D Organoid Platform of InnoModels Biotechnology

As a leader in the life science field, InnoModels Biotechnology (Beijing) Co., Ltd. has always been committed to promoting technological innovation and providing scientists with advanced experimental tools. Among them, the 3D organoid platform of InnoModels Biotechnology opens up a new dimension for cell research and drug development, and shows significant advantages.

09-18

InnoModels Bio's Non-GLP Toxicology Platform

In the vast world of drug development, safety and efficacy are always the two core issues that developers are most concerned about. Toxicology evaluation, as a key link in the process of new drug development, has a direct bearing on the accuracy and reliability of the drug, whether the drug can enter the clinical trial or even go on the market. With its non-GLP (Good Laboratory Practice) toxicology platform, InnoModels Biotechnology (Beijing) Co., Ltd. plays a pivotal role in the field of drug discovery and development, providing a strong safety guarantee for new drug developers.

< 1...3 4 5...61 >

InnoModels Biotechnology (Beijing) Co., Ltd.

Telephone:+8615010000264 +8613810723384
E-mail:cndw@imodels.tech
Address: Building 14, Life Valley, Shuangying West Road, Changping District, Beijing

COOKIES

Our website uses cookies and similar technologies to personalize the advertising shown to you and to help you get the best experience on our website. For more information, see our Privacy & Cookie Policy

COOKIES

required

These cookies are necessary for basic functions such as payment. Standard cookies cannot be turned off and do not store any of your information.

analyze

These cookies collect information, such as how many people are using our site or which pages are popular, to help us improve the customer experience. Turning these cookies off will mean we can't collect information to improve your experience.

Feature

These cookies enable the website to provide enhanced functionality and personalization. They may be set by us or by third-party providers whose services we have added to our pages. If you do not allow these cookies, some or all of these services may not function properly.

advertise

These cookies help us understand what you are interested in so that we can show you relevant advertising on other websites. Turning these cookies off will mean we are unable to show you any personalized advertising.

InnoModels Biotechnology (Beijing) Co., Ltd

SEO

Business License